Home
>
National Drug Code (NDC)
>
LOTEMAX
LOTEMAX - 24208-503-07 - (loteprednol etabonate)
Drug Information of LOTEMAX
| Product NDC: | 24208-503 |
| Proprietary Name: | LOTEMAX |
| Non Proprietary Name: | loteprednol etabonate |
| Active Ingredient(s): | 5 mg/g & nbsp; loteprednol etabonate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LOTEMAX
| Product NDC: | 24208-503 |
| Labeler Name: | Bausch & Lomb Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202872 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121012 |
Package Information of LOTEMAX
| Package NDC: | 24208-503-07 |
| Package Description: | 5 g in 1 BOTTLE (24208-503-07) |
NDC Information of LOTEMAX
| NDC Code | 24208-503-07 |
| Proprietary Name | LOTEMAX |
| Package Description | 5 g in 1 BOTTLE (24208-503-07) |
| Product NDC | 24208-503 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | loteprednol etabonate |
| Dosage Form Name | GEL |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20121012 |
| Marketing Category Name | NDA |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LOTEPREDNOL ETABONATE |
| Strength Number | 5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
